These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 23957964

  • 1. 10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)-a multicenter phase-II trial (CISTAXOL).
    Eberhardt WE, Gauler TC, Lepechoux C, Stamatis G, Bildat S, Krbek T, Welter S, Grunenwald D, Fischer B, Rodrigo Hde L, Theegarten D, Le Chevalier T, Seeber S, Stuschke M, Poettgen C.
    Lung Cancer; 2013 Oct; 82(1):83-9. PubMed ID: 23957964
    [Abstract] [Full Text] [Related]

  • 2. Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE).
    Eberhardt WE, Pöttgen C, Gauler TC, Friedel G, Veit S, Heinrich V, Welter S, Budach W, Spengler W, Kimmich M, Fischer B, Schmidberger H, De Ruysscher D, Belka C, Cordes S, Hepp R, Lütke-Brintrup D, Lehmann N, Schuler M, Jöckel KH, Stamatis G, Stuschke M.
    J Clin Oncol; 2015 Dec 10; 33(35):4194-201. PubMed ID: 26527789
    [Abstract] [Full Text] [Related]

  • 3. Accelerated hyperfractionated radiotherapy within trimodality therapy concepts for stage IIIA/B non-small cell lung cancer: Markedly higher rate of pathologic complete remissions than with conventional fractionation.
    Pöttgen C, Eberhardt W, Graupner B, Theegarten D, Gauler T, Freitag L, Abu Jawad J, Wohlschlaeger J, Welter S, Stamatis G, Stuschke M.
    Eur J Cancer; 2013 Jun 10; 49(9):2107-15. PubMed ID: 23510803
    [Abstract] [Full Text] [Related]

  • 4. Intensified high-dose chemoradiotherapy with induction chemotherapy in patients with locally advanced non-small-cell lung cancer-safety and toxicity results within a prospective trial.
    Pöttgen C, Eberhardt WE, Gauler T, Krbek T, Berkovic K, Jawad JA, Korfee S, Teschler H, Stamatis G, Stuschke M.
    Int J Radiat Oncol Biol Phys; 2010 Mar 01; 76(3):809-15. PubMed ID: 19427744
    [Abstract] [Full Text] [Related]

  • 5. Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.
    Friedel G, Budach W, Dippon J, Spengler W, Eschmann SM, Pfannenberg C, Al-Kamash F, Walles T, Aebert H, Kyriss T, Veit S, Kimmich M, Bamberg M, Kohlhaeufl M, Steger V, Hehr T.
    J Clin Oncol; 2010 Feb 20; 28(6):942-8. PubMed ID: 20100967
    [Abstract] [Full Text] [Related]

  • 6. Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
    Li J, Dai CH, Yu LC, Chen P, Li XQ, Shi SB, Wu JR.
    Clin Lung Cancer; 2009 Sep 20; 10(5):353-9. PubMed ID: 19808194
    [Abstract] [Full Text] [Related]

  • 7. Induction chemotherapy with triweekly docetaxel and cisplatin followed by concomitant chemoradiotherapy with or without surgery in stage III non-small-cell lung cancer: a phase II study.
    Aydiner A, Sen F, Saglam EK, Oral EN, Eralp Y, Tas F, Toker A, Dilege S.
    Clin Lung Cancer; 2011 Sep 20; 12(5):286-92. PubMed ID: 21729649
    [Abstract] [Full Text] [Related]

  • 8. Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial.
    Eberhardt W, Stamatis G, Stuschke M, Wilke H, Müller MR, Kolks S, Flasshove M, Schütte J, Stahl M, Schlenger L, Budach V, Greschuchna D, Stüben G, Teschler H, Sack H, Seeber S.
    Br J Cancer; 1999 Dec 20; 81(7):1206-12. PubMed ID: 10584883
    [Abstract] [Full Text] [Related]

  • 9. Twelve-year follow-up of trimodality therapy for stage IIIA non-small cell lung cancer.
    Weitberg AB, Liu L, Yashar J, Glicksman AS.
    J Exp Clin Cancer Res; 2001 Sep 20; 20(3):335-40. PubMed ID: 11718211
    [Abstract] [Full Text] [Related]

  • 10. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P, Herndon J, Langer M, Kohman LJ, Elias AD, Kass FC, Eaton WL, Seagren SL, Green MR, Sugarbaker DJ.
    Cancer; 1996 Jun 01; 77(11):2393-9. PubMed ID: 8635112
    [Abstract] [Full Text] [Related]

  • 11. Induction chemotherapy followed by concurrent chemotherapy and definitive high-dose radiotherapy for patients with locally advanced non-small-cell lung cancer (stages IIIa/IIIb): a pilot phase I/II trial.
    Pöttgen C, Eberhardt W, Bildat S, Stüben G, Stamatis G, Hillejan L, Sohrab S, Teschler H, Seeber S, Sack H, Stuschke M.
    Ann Oncol; 2002 Mar 01; 13(3):403-11. PubMed ID: 11996471
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial.
    Eberhardt W, Wilke H, Stamatis G, Stuschke M, Harstrick A, Menker H, Krause B, Müeller MR, Stahl M, Flasshove M, Budach V, Greschuchna D, Konietzko N, Sack H, Seeber S.
    J Clin Oncol; 1998 Feb 01; 16(2):622-34. PubMed ID: 9469351
    [Abstract] [Full Text] [Related]

  • 15. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.
    Albain KS, Rusch VW, Crowley JJ, Rice TW, Turrisi AT, Weick JK, Lonchyna VA, Presant CA, McKenna RJ, Gandara DR.
    J Clin Oncol; 1995 Aug 01; 13(8):1880-92. PubMed ID: 7636530
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M, Lee JH, Stevenson JP, Shrager JB, Algazy KM, Treat J, Kaiser LR.
    J Thorac Cardiovasc Surg; 2004 Jan 01; 127(1):108-13. PubMed ID: 14752420
    [Abstract] [Full Text] [Related]

  • 18. Long-term survival results for patients with locally advanced, initially unresectable non-small cell lung cancer treated with aggressive concurrent chemoradiation.
    Langer CJ, Curran WJ, Keller SM, Catalano RB, Litwin S, Blankstein KB, Haas N, Campli SN, Comis RL.
    Cancer J Sci Am; 1996 Jan 01; 2(2):99-105. PubMed ID: 9166507
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial.
    Rusch VW, Albain KS, Crowley JJ, Rice TW, Lonchyna V, McKenna R, Livingston RB, Griffin BR, Benfield JR.
    J Thorac Cardiovasc Surg; 1993 Jan 01; 105(1):97-104; discussion 104-6. PubMed ID: 8380477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.